HHCepo 200 Tablet contains Cefpodoxime Proxetil 200mg, a third-generation oral cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, making it bactericidal. It is indicated for the treatment of respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. The drug exhibits activity against both Gram-positive and Gram-negative organisms, including Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Proteus species. HHCepo 200 is generally well tolerated; common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions, although rare, may occur in patients with a history of penicillin or cephalosporin allergy. Dosage and duration of therapy should be tailored according to the severity of infection and renal function status. It is essential to complete the prescribed course to prevent the development of resistance. HHCepo 200 Tablet should be used under medical supervision, with caution advised in patients with hepatic or renal impairment. This medication is contraindicated in individuals with known hypersensitivity to cephalosporins.